Biochim Biophys Acta. 2004 Mar 11;1697(1-2):137-42.

Cdk5, a therapeutic target for Alzheimer's disease?

Source

Department of Pathology, Harvard Medical School, Howard Hughes Medical Institute, 200 Longwood Avenue, Boston, MA 02115, USA. li-huei_tesai@hms.harvard.edu

Abstract

Alzheimer's disease (AD) represents the leading cause for senile dementia affecting more than 4 million people worldwide. AD patients display a triad of pathological features including brain atrophy caused by neuronal loss, beta-amyloid plaque and neurofibrillary tangles. We previously show that Cyclin-dependent kinase 5 (Cdk5) is deregulated in AD brains and may contribute to the pathogenesis of AD. In AD brains, a calpain cleavage product of its physiological regulator p35, p25 is elevated. p25 causes prolonged activation of Cdk5 and alteration of its substrate specificity. The implications of p25/Cdk5 in neurotoxicity, beta-amyloid plaque and neurofibrillary tangle pathology will be discussed.

PMID:: 15023356; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Supplemental Content

Save items

Related citations in PubMed

Review Cdk5 as a drug target for the treatment of Alzheimer's disease. [J Mol Neurosci. 2002]
Review Cdk5 as a drug target for the treatment of Alzheimer's disease.
Lau LF, Seymour PA, Sanner MA, Schachter JB. J Mol Neurosci. 2002 Dec; 19(3):267-73.
Review Cdk5: one of the links between senile plaques and neurofibrillary tangles? [J Alzheimers Dis. 2003]
Review Cdk5: one of the links between senile plaques and neurofibrillary tangles?
Lee MS, Tsai LH. J Alzheimers Dis. 2003 Apr; 5(2):127-37.
A survey of Cdk5 activator p35 and p25 levels in Alzheimer's disease brains. [FEBS Lett. 2002]
A survey of Cdk5 activator p35 and p25 levels in Alzheimer's disease brains.
Tseng HC, Zhou Y, Shen Y, Tsai LH. FEBS Lett. 2002 Jul 17; 523(1-3):58-62.
Review Role of cdk5 in the pathogenesis of Alzheimer's disease. [Neurosignals. 2003]
Review Role of cdk5 in the pathogenesis of Alzheimer's disease.
Lau LF, Ahlijanian MK. Neurosignals. 2003 Sep-Oct; 12(4-5):209-14.
Review Recent evidence regarding a role for Cdk5 dysregulation in Alzheimer's disease. [Curr Alzheimer Res. 2004]
Review Recent evidence regarding a role for Cdk5 dysregulation in Alzheimer's disease.
Monaco EA 3rd. Curr Alzheimer Res. 2004 Feb; 1(1):33-8.

See reviews... See all...

Cited by 7 PubMed Central articles

S-Nitrosylation activates Cdk5 and contributes to synaptic spine loss induced by beta-amyloid peptide. [Proc Natl Acad Sci U S A. 2011]
S-Nitrosylation activates Cdk5 and contributes to synaptic spine loss induced by beta-amyloid peptide.
Qu J, Nakamura T, Cao G, Holland EA, McKercher SR, Lipton SA. Proc Natl Acad Sci U S A. 2011 Aug 23; 108(34):14330-5. Epub 2011 Aug 15.
Membrane cholesterol modulates {beta}-amyloid-dependent tau cleavage by inducing changes in the membrane content and localization of N-methyl-D-aspartic acid receptors. [J Biol Chem. 2011]
Membrane cholesterol modulates {beta}-amyloid-dependent tau cleavage by inducing changes in the membrane content and localization of N-methyl-D-aspartic acid receptors.
Nicholson AM, Methner DN, Ferreira A. J Biol Chem. 2011 Jan 14; 286(2):976-86. Epub 2010 Nov 3.
A 24-residue peptide (p5), derived from p35, the Cdk5 neuronal activator, specifically inhibits Cdk5-p25 hyperactivity and tau hyperphosphorylation. [J Biol Chem. 2010]
A 24-residue peptide (p5), derived from p35, the Cdk5 neuronal activator, specifically inhibits Cdk5-p25 hyperactivity and tau hyperphosphorylation.
Zheng YL, Amin ND, Hu YF, Rudrabhatla P, Shukla V, Kanungo J, Kesavapany S, Grant P, Albers W, Pant HC. J Biol Chem. 2010 Oct 29; 285(44):34202-12. Epub 2010 Aug 18.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Cdk5, a therapeutic target for Alzheimer's disease?
Cdk5, a therapeutic target for Alzheimer's disease?
Biochim Biophys Acta. 2004 Mar 11 ;1697(1-2):137-42.

PubMed
Anchoring notch genetics and biochemistry; structural analysis of the ankyrin do...
Anchoring notch genetics and biochemistry; structural analysis of the ankyrin domain sheds light on existing data.
Mol Cell. 2004 Mar 12 ;13(5):619-26.

PubMed
Reaction of Pseudomonas fluorescens kynureninase with beta-benzoyl-L-alanine: de...
Reaction of Pseudomonas fluorescens kynureninase with beta-benzoyl-L-alanine: detection of a new reaction intermediate and a change in rate-determining step.
Biochemistry. 2004 Mar 23 ;43(11):3230-7.

PubMed
Palliative care: an emerging issue for American Indians and Alaskan Natives.
Palliative care: an emerging issue for American Indians and Alaskan Natives.
J Pain Palliat Care Pharmacother. 2003 ;17(3-4):201-10.

PubMed
Pain relief in the developing world: the experience of hospice Africa-Uganda.
Pain relief in the developing world: the experience of hospice Africa-Uganda.
J Pain Palliat Care Pharmacother. 2003 ;17(3-4):107-18; discussion 119-20.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Cdk5, a therapeutic target for Alzheimer's disease?

Source

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Supplemental Content

Save items

Related citations in PubMed

Cited by 7 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information